Recovering The SelfA Journal of Hope and Healing

News

Zantac Recalled Over Concern of Contamination with Carcinogen

In an important health alert, media in US and abroad have reported on public about the recall of some brands of Ranitidine, the anti-acid/heartburn medicine commonly sold under the generic name Zantac.

MedScape reported on September 24th that pharmaceutical company Sandoz Inc. has “voluntarily recalled all generic Zantac” in the United States because some batches of the medicine were found to be contaminated with N-nitrosodimethylamine (NDMA), which is a carcinogen (cancer-causing substance).

On Wednesday, September 25th, Global News reported that four more companies have recalled Zantac over the same concern of NDMA contamination. These companies are: Apotex Inc, Pro Doc Limitée, Sanis Health Inc, and Sivem Pharmaceuticals ULC.  The story says that Sandoz had already recalled the drug in Canada and other countries.

Share This Page

PinIt

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Read in Your Language

Buy RTS on Amazon

Be the first to see new posts

Subscribe to our blog here and be notified immediately when helpful posts come in.

Thanks for subscribing!

DISCLAIMER: please read

Recovering The Self is a forum for people to tell their stories. Individual contributors accept complete responsibility for the veracity, accuracy, and non-infringement of their reporting.
Inclusion in Recovering The Self is neither an endorsement nor a confirmation of claims presented within. Sole responsibility lies with individual contributors, not the editor, staff, or management of Recovering The Self Journal.
Malcare WordPress Security